NCT00208767View on ClinicalTrials.gov

Effect of Valsartan on Carotid Artery Disease

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

February 28, 2005

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions
Carotid Artery DiseasesAtherosclerosis
Interventions
DRUG

Valsartan

Valsartan was titrated to a target dose of 320 mg orally daily

DRUG

Placebo

A matched placebo pill will be given orally daily.

Trial Locations (1)

30322

Emory University School of Medicine, Atlanta

All Listed Sponsors
lead

Emory University

OTHER

NCT00208767 - Effect of Valsartan on Carotid Artery Disease | Biotech Hunter | Biotech Hunter